Silicon Valley VC backs Raleigh startup with ties to Joe DeSimone that’s targeting pancreatic cancer
A Raleigh life science startup targeting pancreatic cancer and other diseases with what it calls a “novel” drug delivery system developed at UNC-Chapel Hill, has $5.5 million in new capital to fund further research in a round led by Silicon Valley venture capital firm Khosla Ventures.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed